Home » Authors » Jim Stommen

Articles by Jim Stommen

McClellan sees CMS, industry partnering in innovation push

March 7, 2005

Panel: In order to avoid pitfalls, start reimbursement drive early

March 4, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 6, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 4, 2005

Growing convergence of technologies interests clinicians, industry

June 1, 2004

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

Innovative technologies from smaller cardio firms stir interest

March 1, 2002

It's no MIRACLE that new EP therapies are being ADOPTed

July 1, 2001

Big hitters, emerging firms tell their tales at Piper Jaffray gathering

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.